Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer: screening and early detection update

N S Berger1

  • 1Division of Urology, University of Colorado Health Sciences Center, Denver 80262.

Seminars in Oncology Nursing
|August 1, 1993
PubMed
Summary

Prostate cancer screening involves digital rectal exams (DRE) and prostate-specific antigen (PSA) tests. Combining DRE and PSA offers the most effective and cost-efficient approach for early detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Being sensitive to the psychological needs of patients with prostate cancer.

Oncology nursing forum·1995
Same author

Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime.

The Journal of urology·1992
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Medical Screening

Background:

  • Prostate cancer etiology remains incompletely understood.
  • Screening methodologies for prostate cancer are continually advancing.
  • Understanding the nuances of screening tools is crucial for effective patient management.

Purpose of the Study:

  • To evaluate the efficacy and cost-effectiveness of various prostate cancer screening methods.
  • To highlight key considerations for current prostate cancer screening practices.

Main Methods:

  • Review of existing prostate cancer screening modalities.
  • Analysis of the specificity and utility of Prostate-Specific Antigen (PSA) testing.
  • Assessment of Digital Rectal Examination (DRE) as a standard screening tool.
  • Evaluation of Transrectal Ultrasound (TRUS) in the context of screening costs and accessibility.

Main Results:

  • Prostate-Specific Antigen (PSA) is organ-specific but not cancer-specific.
  • Digital Rectal Examination (DRE) is established as a primary screening method.
  • Transrectal Ultrasound (TRUS) shows evolving capabilities but is currently cost-prohibitive for widespread screening.
  • A combined approach utilizing both DRE and PSA demonstrates superior effectiveness and cost-efficiency.

Conclusions:

  • The combination of DRE and PSA represents the optimal strategy for prostate cancer screening.
  • Despite ongoing controversies, mass prostate cancer screening is being implemented.
  • Clinicians and patients must comprehend the strengths and limitations of available screening technologies.

Related Experiment Videos